CN103948652A - Method for drying lucid ganoderma - Google Patents

Method for drying lucid ganoderma Download PDF

Info

Publication number
CN103948652A
CN103948652A CN201410204925.8A CN201410204925A CN103948652A CN 103948652 A CN103948652 A CN 103948652A CN 201410204925 A CN201410204925 A CN 201410204925A CN 103948652 A CN103948652 A CN 103948652A
Authority
CN
China
Prior art keywords
ganoderma
dry
drying
temperature
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410204925.8A
Other languages
Chinese (zh)
Inventor
许翠萍
丁桂丽
赵建东
赵颖
李诗标
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Original Assignee
Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Kangzhong Pharmaceutical Research and Development Co Ltd filed Critical Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Priority to CN201410204925.8A priority Critical patent/CN103948652A/en
Publication of CN103948652A publication Critical patent/CN103948652A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a method for drying lucid ganoderma. The method is characterized by comprising the steps of collecting newly harvested lucid ganoderma, removing impurities, thoroughly steaming and lyophilizing. According to the lucid ganoderma prepared by the drying method, the main effective components are high in content of polysaccharides and strong in anti-cancer activity.

Description

The drying means of a kind of Ganoderma
Invention field
The present invention relates to medicine method for making, particularly the drying means of a kind of Ganoderma, belongs to medical technical field.
Background technology
Ganoderma is On Polyporaceae Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganodermalucidum (Leyss.ExFr.) Karst. or Ganoderma GanodermasinenseZhao, the dry sporophore of XuetZhang.There is invigorating QI and tranquilization, the effect of relieving cough and asthma, for dizzy sleeplessness, shortness of breath and palpitation, asthenia cough with asthma.Modern study proves, Ganoderma contains aminoacid, polypeptide, protein, and saccharide, ergosterol, triterpenes etc.Have and calm the nerves, regulate immunity, resist myocardial ischemia, anti-antiplatelet aggregation and antithrombotic, protect the liver, antioxidation, antiinflammatory, antitumor action.
What < < Chinese Pharmacopoeia > > recorded gathers and processing method, gather the whole year, remove impurity, wipe out the lower end stem with rotten wood, silt or culture matrix, dry in the shade or 40~50 ℃ of oven dry.
Summary of the invention
The drying means that the object of this invention is to provide a kind of Ganoderma, the Ganoderma that the method is dry, main effective ingredient polyoses content high resistance, cancer is active strong.
The present invention is achieved in that
A drying means for Ganoderma, is characterized in that: get the Ganoderma of newly gathering, remove impurity, steam thoroughly lyophilizing.
The drying means of a kind of Ganoderma of the present invention, is characterized in that: lyophilizing is to be refrigerated to below-20 ℃, be evacuated to below drying chamber pressure 30Pa, and subliming by heating, the temperature of distillation is controlled at below 40 ℃, and the temperature of resolution phase should be controlled at below 45 ℃, to dry.
So far completed the present invention, the Ganoderma of preparing by drying means of the present invention, main effective ingredient polyoses content high resistance, cancer is active strong.
Below by test example, further illustrate usefulness of the present invention, test example is intended to further illustrate usefulness of the present invention, but not limitation of the present invention.
By with a collection of Ganoderma of newly gathering, remove impurity, process by the following method.
1) dry: shady and cool ventilation place, spread out and dry;
2) dry: 60 ℃ of following oven dry;
3) steam rear lyophilizing: get the Ganoderma of newly gathering, remove impurity, steam 15 minutes, through watching, steam, take out, put in fridge, be refrigerated to-20 ℃, be evacuated to drying chamber pressure 30Pa, subliming by heating, the temperature of distillation is controlled at 40 ℃, and the temperature of resolution phase should be controlled at 45 ℃, to dry.
One, the dry ganoderma polyoses content comparison of distinct methods
The preparation of reference substance solution: get glucose reference substance appropriate, accurately weighed, add water and make every 1ml containing the solution of 0.1mg, obtain.
The preparation of standard curve: precision measures reference substance solution 0.2ml respectively, 0.4m1, 0.6ml, 0.8ml, 1.0ml, 1.2ml, put in 10ml tool plug test tube, add water to 2.0ml, precision adds sulphuric acid anthrone solution, and (precision takes anthrone 0.1g, adding 80% sulfuric acid solution 100ml makes to dissolve, shake up) 6ml, shake up, put in water-bath and heat 15 minutes, take out, put in people's ice bath cooling 15 minutes, take corresponding reagent as blank, according to < < Chinese Pharmacopoeia > > ultraviolet visible spectrophotometry, at 625nm wavelength place, measure absorbance, take absorbance as vertical coordinate, concentration is abscissa, drawing standard curve.
The preparation of need testing solution: get the about 2g of each sample powder, accurately weighed, put in apparatus,Soxhlet's, add water 90ml, electric heater heating and refluxing extraction is to extracting liquid colourless, and extracting solution is transferred in 100ml measuring bottle, adds water to scale, shaking up. precision measures 10ml, adds ethanol 150ml, shakes up, place 12 hours for 4 ℃, take out, centrifugal, the supernatant that inclines, precipitation is dissolved in water, and is transferred in 50ml measuring bottle, add water to scale, shake up, obtain.
Algoscopy: precision measures need testing solution 2ml, put in 10ml tool plug test tube, method under the preparation of sighting target directrix curve, from " precision adds sulphuric acid anthrone solution 6ml ", measure absorbance in accordance with the law, from standard curve, read the weight (mg) that contains glucose in need testing solution, calculate, obtain.
Press dry product and calculate, containing ganoderan, in anhydrous glucose (C6H12O6), the results are shown in Table 1.
Table 1 distinct methods is dried ganoderma polyoses content (%)
Drying means Dry Dry Lyophilizing after steaming
Content (%) 1.76 1.74 3.45
By table 1, found out, Ganoderma " lyophilizing after steaming ", polyoses content is apparently higher than " drying " and " oven dry ".
Two, the dry anti-human lung of Ganoderma source adenocarcinoma cell SPCA-1, human hepatoma cell line HepG2 and the people's chronic myelogenous leukemia cell K562 test of distinct methods.
1, prepare Ganoderma extract and get respectively the dry Ganoderma pulverizing of distinct methods, respectively decoct with water twice, add for the first time 8 times of amounts of water, decoct 2 hours, add for the second time 8 times of amounts of water, decoct 1 hour, merge medicinal liquid, medicinal liquid filters, and gets filtrate, and being concentrated into relative density is 1.10(60 ℃) time, add ethanol to make to reach 75% containing alcohol amount, precipitation, standing 36 hours, draw supernatant, reclaim ethanol, concentrated, dry, pulverize, obtain the dry Ganoderma extract of distinct methods.
2, tumor cell line people lung source adenocarcinoma cell SPCA-1, human hepatoma cell line HepG2 and people's chronic myelogenous leukemia cell K562, use RPMI-1649 culture fluid, and 37 ℃, 5%CO2, relative humidity 100% is cultivated, and attached cell 0.25% trypsinization goes down to posterity.
3, the inhibitory action of method MTT colorimetric method for determining extract to growth of tumour cell.The trophophase cell of taking the logarithm, is mixed with cell suspension with fresh RPMI-1640 culture fluid, 0.8 * 105/ml of 1 * 105/ml of suspension cell attached cell.Suspension cell is inoculated in 96 well culture plates after adding respectively variable concentrations Experimental agents; Attached cell is first inoculated in 96 well culture plates, after every hole 90 μ l24h, adds respectively variable concentrations Experimental agents.Final volume is that every hole 100 μ l and every group are established 3 parallel holes, establishes altogether 4 groups: be subject to reagent group T (culture fluid+cell suspension+variable concentrations is subject to reagent), negative control group N (culture fluid+cell suspension), medicine color matched group TC (culture fluid+variable concentrations is subject to reagent), blank group B (culture fluid+normal saline).Tested concentration is followed successively by 10 μ g/ml, 30 μ g/ml, 50 μ g/ml.Put 37 ℃, in 5%CO2 incubator, cultivate after 72h, after adding the 10 μ l concussions of MTT solution to mix to every hole, continue to cultivate 4h, add SDS90 μ l to stop cultivating, 37 ℃ are spent the night, and then under room temperature, on micro oscillator, shake 10min, microplate reader is measured the absorbance (OD value) at 570nm wavelength place, and experiment repeats 3 times.
Calculate as follows growth inhibition ratio:
Growth inhibition ratio (%)=(N group OD average-B group OD average)-(T group OD average-TC group OD average)/N group OD average-B group OD average * 100%.
4, different extracts to the suppression ratio of people's lung source adenocarcinoma cell SPCA-1, human hepatoma cell line HepG2 and people's chronic myelogenous leukemia cell K562 the results are shown in Table 2, table 3, table 4.
The suppression ratio result of table 2 couple SPCA-1
Suppression ratio (%) 10(μg/ml) 30(μg/ml) 50(μg/ml)
Dry 46.52 53.42 66.51
Dry 46.47 53.50 66.53
Lyophilizing after steaming 61.73 74.87 83.16
The suppression ratio result of table 3 couple HepG2
Suppression ratio (%) 10(μg/ml) 30(μg/ml) 50(μg/ml)
Dry 43.62 54.74 58.67
Dry 43.61 54.71 58.64
Lyophilizing after steaming 58.42 71.23 87.52
The suppression ratio result of table 4 couple K562
Suppression ratio (%) 10(μg/ml) 30(μg/ml) 50(μg/ml)
Dry 57.29 68.44 74.65
Dry 57.31 68.42 74.62
Lyophilizing after steaming 67.24 76.35 86.91
Result shows, the dry Ganoderma of distinct methods all has inhibitory action to the propagation of SPCA-1, HepG2, K562 cell, and wherein, after steaming, lyophilizing curative effect is best.
The specific embodiment
A drying means for Ganoderma, is characterized in that: get the Ganoderma of newly gathering, remove impurity, steam thoroughly, be refrigerated to below-20 ℃, be evacuated to below drying chamber pressure 30Pa subliming by heating, the temperature of distillation is controlled at below 40 ℃, and the temperature of resolution phase should be controlled at below 45 ℃, to dry.
embodiment 1
Get the Ganoderma of newly gathering, remove impurity, steam 10 minutes, through checking, steam, take out, put in fridge, be refrigerated to-25 ℃, be evacuated to drying chamber pressure 35Pa, subliming by heating, the temperature of distillation is controlled at below 35 ℃, and the temperature of resolution phase should be controlled at 40 ℃, to dry.
embodiment 2
Get the Ganoderma of newly gathering, remove impurity, steam 15 minutes, through checking, steam, take out, put in fridge, be refrigerated to-32 ℃, be evacuated to drying chamber pressure 40Pa, subliming by heating, the temperature of distillation is controlled at below 30 ℃, and the temperature of resolution phase should be controlled at 40 ℃, to dry.
embodiment 3
Get the Ganoderma of newly gathering, remove impurity, steam 20 minutes, through checking, steam, take out, put in fridge, be refrigerated to-28 ℃, be evacuated to drying chamber pressure 50Pa, subliming by heating, the temperature of distillation is controlled at below 40 ℃, and the temperature of resolution phase should be controlled at 45 ℃, to dry.
embodiment 4
Get the Ganoderma of newly gathering, remove impurity, steam 20 minutes, through checking, steam, take out, put in fridge, put in freeze dryer, solidification point is controlled at-30 ℃; Reach and control after temperature, open immediately vacuum pump and be evacuated to below drying chamber pressure 50Pa, then start heater switch, promote distillation; The temperature of distillation should be controlled at below 40 ℃; The temperature of resolution phase should be controlled at below 45 ℃, to dry.

Claims (2)

1. a drying means for Ganoderma, is characterized in that: get the Ganoderma of newly gathering, remove impurity, steam thoroughly lyophilizing.
2. according to the drying means of a kind of Ganoderma of claim 1, it is characterized in that: lyophilizing is to be refrigerated to below-20 ℃, is evacuated to below drying chamber pressure 30Pa, subliming by heating, the temperature of distillation is controlled at below 40 ℃, and the temperature of resolution phase should be controlled at below 45 ℃, to dry.
CN201410204925.8A 2014-05-15 2014-05-15 Method for drying lucid ganoderma Pending CN103948652A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410204925.8A CN103948652A (en) 2014-05-15 2014-05-15 Method for drying lucid ganoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410204925.8A CN103948652A (en) 2014-05-15 2014-05-15 Method for drying lucid ganoderma

Publications (1)

Publication Number Publication Date
CN103948652A true CN103948652A (en) 2014-07-30

Family

ID=51326094

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410204925.8A Pending CN103948652A (en) 2014-05-15 2014-05-15 Method for drying lucid ganoderma

Country Status (1)

Country Link
CN (1) CN103948652A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104142046A (en) * 2014-08-25 2014-11-12 济南康众医药科技开发有限公司 Method for drying eucommia ulmoides
CN104142047A (en) * 2014-08-25 2014-11-12 济南康众医药科技开发有限公司 Eucommia freeze-drying method
CN104154714A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Method of adopting freeze-drying technology to prepare high-activity lamiophlomis rotata decoction pieces
CN104154718A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of cortex magnoliae officinalis
CN104154709A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method for radix tetrastigme
CN104154721A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Rehmannia freeze-drying method
CN104154720A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Application of freeze-drying technology in eucommia ulmoides drying
CN104147059A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of penthorum chinense pursh
CN104154722A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Application of freeze-drying technology in lamiophlomis rotata drying
CN104154713A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Lamiophlomis freeze-drying method
CN104165497A (en) * 2014-08-25 2014-11-26 济南康众医药科技开发有限公司 Honeysuckle freeze-drying method
CN104180611A (en) * 2014-08-25 2014-12-03 济南康众医药科技开发有限公司 Application of freeze-drying technology in mangnolia officinalis
CN104197645A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Gymnadenia conopsea freeze-drying method
CN104197646A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Drying method of magnolia officinalis and application of magnolia officinalis product

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘文彬 等: "《灵芝育种栽培与加工技术》", 31 May 2000, article "冷冻干燥法", pages: 127-128 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104142046A (en) * 2014-08-25 2014-11-12 济南康众医药科技开发有限公司 Method for drying eucommia ulmoides
CN104142047A (en) * 2014-08-25 2014-11-12 济南康众医药科技开发有限公司 Eucommia freeze-drying method
CN104154714A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Method of adopting freeze-drying technology to prepare high-activity lamiophlomis rotata decoction pieces
CN104154718A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of cortex magnoliae officinalis
CN104154709A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method for radix tetrastigme
CN104154721A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Rehmannia freeze-drying method
CN104154720A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Application of freeze-drying technology in eucommia ulmoides drying
CN104147059A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of penthorum chinense pursh
CN104154722A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Application of freeze-drying technology in lamiophlomis rotata drying
CN104154713A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Lamiophlomis freeze-drying method
CN104165497A (en) * 2014-08-25 2014-11-26 济南康众医药科技开发有限公司 Honeysuckle freeze-drying method
CN104180611A (en) * 2014-08-25 2014-12-03 济南康众医药科技开发有限公司 Application of freeze-drying technology in mangnolia officinalis
CN104197645A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Gymnadenia conopsea freeze-drying method
CN104197646A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Drying method of magnolia officinalis and application of magnolia officinalis product

Similar Documents

Publication Publication Date Title
CN103948652A (en) Method for drying lucid ganoderma
CN103977041A (en) Drying method of ganoderma applanatum pat
CN103948638A (en) Drying method of medical fungi
CN103977040A (en) Lucid ganoderma drying method
CN103968647B (en) The drying means of a kind of gold sesame
CN103977034A (en) Drying method of medicinal fungi
CN103919712A (en) Cordyceps militaris extract, and preparation method and application thereof
CN103316096A (en) General flavone extract of seeds of nigella damascena l., nigella sativa l. or nigella glandulifera freyn et sint., and preparation method and use thereof
CN103169741A (en) Application of freeze-dried portulaca oleracea L. in preparation of anti-fatigue medicament
CN104367595A (en) Application of American cockroach dried by different methods in preparation of medicines
CN103948650A (en) Drying method of artist&#39;s conk
CN101974095A (en) Method for extracting and separating Chinese narcissus polysaccharides
CN103977036A (en) Drying method of inonotus obliquus
CN103055098A (en) Freeze-dried yam for preventing and treating cancer
CN104031162B (en) Radix Ophiopogonis polysaccharide, method for extraction and purification and the application as tobacco humectant thereof
CN101766662B (en) Process for efficiently concentrating cordycepin
CN104138403A (en) Drying method of radix tetrastigme
CN104922268B (en) A kind of method that active material is extracted from natural plants
CN103948651A (en) Application of freezing technology in drying of lucid ganoderma
CN103263461A (en) Application of silktree albizia bark water extract in preparation of anti-tumor medicaments
CN103070893A (en) Medicine prepared by purslane and used for treating senile dementia
CN103977042A (en) Application of refrigeration technology for drying Ganoderma applanatum
CN103169752A (en) Semen momordicae extractive as well as preparation method and use thereof
CN103948641A (en) Drying method of Cordyceps
CN103948643A (en) Method for drying inonotus obliquus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140730